International AIDS Conference

International AIDS Conference
Name	International AIDS Conference
Status	Active
Genre	Public health conference
Frequency	Biennial (since 1994)
Country	International
First	1985
Organiser	International AIDS Society
Attendance	Up to 25,000

Contents

International AIDS Conference is the largest global gathering focused on AIDS and HIV research, policy, clinical care, and advocacy. The conference convenes scientists, clinicians, public health officials, activists, representatives from World Health Organization, UNAIDS, Centers for Disease Control and Prevention, pharmaceutical companies such as Gilead Sciences and ViiV Healthcare, and civil society organizations including Médecins Sans Frontières and amfAR. It serves as a forum for presentation of pivotal studies from institutions like Harvard University, University of California, San Francisco, Imperial College London, and Johns Hopkins University while attracting delegations from national health ministries such as the National Health Service (England), South African National Department of Health, and Ministry of Health (Brazil).

History

The inaugural gathering in 1985 brought together researchers from centers including Centers for Disease Control and Prevention and Institut Pasteur alongside activists from groups like AIDS Coalition to Unleash Power and Gay Men's Health Crisis. Early conferences reflected tensions between biomedical research from laboratories such as National Institutes of Health and community responses coordinated by organizations like amfAR and Terrence Higgins Trust. During the 1990s, breakthroughs presented at meetings included antiretroviral developments from companies such as Merck & Co., GlaxoSmithKline, and collaborations with academic groups at Columbia University and University of California, San Diego. The shift to biennial scheduling after 1994 paralleled expanded participation by UNAIDS and World Health Organization, and venues moved among cities including Paris, Vancouver, Bangkok, Barcelona, and Washington, D.C..

The conference is organized by the International AIDS Society through a steering structure that includes scientific committees populated by investigators from Yale University, Duke University School of Medicine, Karolinska Institutet, and representatives from non-governmental organizations like International Planned Parenthood Federation and Human Rights Watch. Governance involves partnerships with funding agencies including the Bill & Melinda Gates Foundation, U.S. President's Emergency Plan for AIDS Relief, and multilaterals such as Global Fund to Fight AIDS, Tuberculosis and Malaria. Host city selection engages municipal authorities such as City of Durban officials and national visa authorities, often requiring liaison with foreign ministries like Foreign and Commonwealth Office (United Kingdom) or Department of State (United States).

Scientific programs feature plenaries, symposia, and poster sessions where investigators from Fred Hutchinson Cancer Research Center, Massachusetts General Hospital, Karolinska Institutet, and University of Cape Town present data on antiretroviral therapy, pre-exposure prophylaxis research from teams at University of KwaZulu-Natal and Fred Hutch, vaccine trials connected to National Institute of Allergy and Infectious Diseases, and cure research with contributions from Ragon Institute and Gladstone Institutes. Sessions integrate work on coinfections managed by Centers for Disease Control and Prevention and World Health Organization guidance, implementation science from London School of Hygiene & Tropical Medicine, and epidemiology modeled by groups at Imperial College London and Institute for Health Metrics and Evaluation. Community-led tracks involve activists from ACT UP, Treatment Action Campaign, and Global Network of People Living with HIV, while poster halls include submissions from investigators at Scripps Research and Weill Cornell Medicine.

The 1996 meeting showcased results affirming combination antiretroviral therapy efficacy originating from trials affiliated with University of Oxford and McGill University, altering standards promoted by World Health Organization. The 2000 conference catalyzed debates on access in locations such as Cape Town and policy shifts involving Brazilian Ministry of Health programs. The 2016 conference in Durban marked a return to South Africa with extensive participation by Treatment Action Campaign and presentations from University of the Witwatersrand that influenced national scale-up of treatment. High-profile addresses have come from leaders associated with Bill & Melinda Gates Foundation, former heads of state such as delegations linked to Nelson Mandela Foundation, and ministers from Ministry of Health (Kenya) and Ministry of Health and Family Welfare (India).

Findings presented have informed policy at agencies including World Health Organization, UNAIDS, and national programs like Brazilian Ministry of Health and South African National Department of Health. Advocacy occurring at the conference has accelerated access campaigns led by Médecins Sans Frontières, amfAR, and Treatment Action Campaign, influenced procurement strategies involving Gilead Sciences and ViiV Healthcare, and catalyzed initiatives funded by Bill & Melinda Gates Foundation and Global Fund to Fight AIDS, Tuberculosis and Malaria. Collaborations seeded at meetings have linked research centers such as Johns Hopkins University and University of Washington with implementation partners like Clinton Health Access Initiative.

The conference has faced disputes over venue choices, as with debates about hosting in cities governed by officials from Republic of China or Government of Russia and responses from human rights advocates including Human Rights Watch. Criticism has also arisen regarding sponsorship ties to pharmaceutical firms including Gilead Sciences and GlaxoSmithKline, prompting scrutiny from civil society groups like ACT UP and Global Network of People Living with HIV. Contentions over travel restrictions and visas involved negotiations with ministries such as Department of Home Affairs (South Africa) and U.S. Department of State, and scientific controversies have entailed disputes among investigators from National Institutes of Health, Imperial College London, and community researchers from University of Cape Town.

Category:HIV/AIDS conferences